UK NICE Review Needs To Be More Than A ‘Bureaucratic Exercise’
Executive Summary
A review of UK HTA body NICE’s methods for appraising medicines will probably be constrained by budget considerations, but it should still aim to bring positive change, said Leslie Galloway of the Ethical Medicines Industry Group.
You may also be interested in...
Brexit Issues Lead NICE To Delay Methods Review
England’s health technology appraisal body, NICE, and the UK medicines regulator, the MHRA, are working together to align their process timelines so that access to medicines is “maintained and enhanced.”
UK Politicians Want NICE To Use Conditional Reimbursement
A UK parliamentary report has called for the HTA body NICE to consider the use of conditional reimbursement recommendations and more flexible cost-effectiveness thresholds in its ongoing methods review.
NICE Expands On Methods Review Details
UK health technology appraisal body NICE has released more details about its forthcoming review of the methods it uses for developing guidance on medicines and medical devices.